PD-1 and PD-L1 pair, the leading immune checkpoint pathway in the TME, plays a immunosuppressive role by suppressing the function of T cells and tumor-infiltrating lymphocytes, resultingly promoting tumor progression [96, 97]. Here, CD274 is linked to neoplasm.